OBSIDIAN THERAPEUTICS Trademark

Trademark Overview

On Tuesday, July 23, 2019, a trademark application was filed for OBSIDIAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBSIDIAN THERAPEUTICS trademark a serial number of 88982707. The federal status of this trademark filing is REGISTERED as of Tuesday, October 19, 2021. This trademark is owned by Obsidian Therapeutics, Inc.. The OBSIDIAN THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and gene and cell modification procedures
obsidian therapeutics

General Information

Serial Number88982707
Word MarkOBSIDIAN THERAPEUTICS
Filing DateTuesday, July 23, 2019
Status700 - REGISTERED
Status DateTuesday, October 19, 2021
Registration Number6531766
Registration DateTuesday, October 19, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of the wording "OBSIDIAN THERAPEUTICS" to the right of a seven-sided heptagon shape with lines within the heptagon that create three triangular elements surrounding a quadrilateral.
Goods and ServicesPharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and gene and cell modification procedures

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code042
First Use Anywhere DateThursday, July 25, 2019
First Use In Commerce DateThursday, July 25, 2019

Trademark Owner History

Party NameObsidian Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 19, 2021REGISTERED-PRINCIPAL REGISTER
Friday, September 17, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 16, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 19, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 18, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 11, 2021USE AMENDMENT FILED
Wednesday, August 18, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, August 11, 2021DIVISIONAL REQUEST RECEIVED
Wednesday, August 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 11, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 11, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021EXTENSION 2 GRANTED
Thursday, February 11, 2021EXTENSION 2 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020EXTENSION 1 GRANTED
Friday, August 7, 2020EXTENSION 1 FILED
Friday, August 7, 2020TEAS EXTENSION RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2019ASSIGNED TO LIE
Wednesday, November 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 8, 2019NON-FINAL ACTION E-MAILED
Sunday, September 8, 2019NON-FINAL ACTION WRITTEN
Friday, September 6, 2019ASSIGNED TO EXAMINER
Thursday, August 1, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 26, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics obsidian gene cell therapy medicine regenerative infectious disease procedures modification immunotherapy